The latest data point for CLS's EPS Diluted in Q4'25 stands at 2.35 USD, marking a robust quarterly performance and the highest value in the series. This figure reflects a year-over-year growth of 104.35%, underscoring continued profitability momentum into the end of fiscal 2025. Over the period from Q1'23 to Q4'25, EPS Diluted has exhibited a strong overall upward trend, rising from 0.2 USD to 2.35 USD, with notable acceleration in 2025 where values surged from 0.74 USD in Q1'25 to over 2 USD in subsequent quarters. Key inflection points include a temporary dip in Q3'24 to 0.77 USD and a slight decline in Q1'25 to 0.74 USD, but these were followed by rapid recoveries, highlighting resilience amid volatility; YoY growth rates were particularly volatile, peaking at 325% in Q1'24 before turning negative at -12.94% in Q1'25, yet rebounding to 200% in Q3'25. This bar and line chart combination reveals a dominant growth pattern, with EPS consistently expanding despite periodic fluctuations, signaling positive long-term earnings trajectory for financial analysts to monitor.